Tenon Medical (TNONW) Net Equity Issued and Repurchased (2023 - 2025)

Tenon Medical's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $4.0 million for Q1 2025.

• In Q1 2025, Net Equity Issued and Repurchased rose 53.93% year-over-year to $4.0 million; the TTM figure through Jun 2025 stood at $4.1 million (up 277.62% YoY), while the FY2024 annual figure was $2.1 million, up 325.45% from the prior year.
• Net Equity Issued and Repurchased for Q1 2025 stood at $4.0 million, up from -$499000.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $4.0 million in Q1 2025, with the low at -$4.4 million in Q3 2023.
• The 3-year median for Net Equity Issued and Repurchased is $42000.0 (2023), against an average of $257571.4.
• Peak annual rise in Net Equity Issued and Repurchased reached 114.12% in 2024, while the deepest fall reached 1288.1% in 2024.
• Tenon Medical's Net Equity Issued and Repurchased stood at $42000.0 in 2023, then tumbled by 1288.1% to -$499000.0 in 2024, then surged by 903.61% to $4.0 million in 2025.
• Business Quant data shows TNONW's Net Equity Issued and Repurchased at $4.0 million in Q1 2025, -$499000.0 in Q4 2024, and $615000.0 in Q3 2024.